NCT04230941
Breast Cancer Type: HER2+, HR+ & HER2-negative, Triple Negative
Hormone Mutations: ER+, PR+
Other Mutations:
Breast Cancer Tissue:
Recruitment Status: Recruiting
Not Applicable
Drug Category: Other
Key Eligibility Criteria:
Gender: All
Age: 65 Years and older (Older Adult)
Location of Metastases:
Additional Notes:
Exclusions: Patients under the age of 65
https://ClinicalTrials.gov/show/NCT04230941